BSSFA
TXG icon

Baron Silver Stevens Financial Advisors’s 10x Genomics TXG Stock Holding History

Baron Silver Stevens Financial Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16
Closed -$2K – 434
2020
Q4 		$2K Buy
+16
New +$2.32K ﹤0.01% 413

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $151M AUM 26.94% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Baron Silver Stevens Financial Advisors's TXG Position: Q1 2021 in Review

Baron Silver Stevens Financial Advisors sold out of 10x Genomics (TXG) in Q1 2021, closing a stake of 16 shares — an estimated $2K sold.

Baron Silver Stevens Financial Advisors first reported a position in TXG in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 324 funds tracked by Wall St. Rank hold TXG as of Q1 2021.

  • Baron Silver Stevens Financial Advisors reported no remaining 10x Genomics position as of Q1 2021 after selling out during the quarter.
  • Baron Silver Stevens Financial Advisors sold 16 10x Genomics shares in Q1 2021, an estimated $2K.
  • Baron Silver Stevens Financial Advisors first reported a position in 10x Genomics in Q4 2020 and held it in 1 quarter.
  • Baron Silver Stevens Financial Advisors's 10x Genomics position peaked at $2K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2021.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.